Role of NF-kappaB and cytokine in experimental cancer cachexia.
about
Molecular and cell-based therapies for muscle degenerations: a road under constructionIKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDSSkeletal muscle wasting and renewal: a pivotal role of myokine IL-6Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer CachexiaMolecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy.Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment.Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice.Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist.Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouseIndomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Anorexia in cancer: role of feeding-regulatory peptides.NF-κBp65 and Expression of Its Pro-Inflammatory Target Genes Are Upregulated in the Subcutaneous Adipose Tissue of Cachectic Cancer Patients.Signal transduction network leading to COX-2 induction: a road map in search of cancer chemopreventives.Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivoCCAAT/enhancer binding protein beta protects muscle satellite cells from apoptosis after injury and in cancer cachexiaMurine models of atrophy, cachexia, and sarcopenia in skeletal muscle.Magnolol attenuates sepsis-induced gastrointestinal dysmotility in rats by modulating inflammatory mediatorsInflammatory fibroblasts in cancer.Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials.Brucea javanica oil emulsion alleviates cachexia induced by Lewis lung cancer cells in mice.Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia.Ultrastructural changes, nuclear factor-kappaB activation, and tumor necrosis factor-alpha expression in brain after acute normovolemic hemodilution and controlled hypotension in rats.Ketamine suppresses intestinal NF-kappa B activation and proinflammatory cytokine in endotoxic rats.Ketamine suppresses endotoxin-induced NF-kappaB activation and cytokines production in the intestine.Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor-bearing mice.Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.Conjugated linoleic acid preserves muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma.Inhibitors of COX activity preserve muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma.Shen-Fu attenuates endotoxin-induced acute lung injury in rats.
P2860
Q24568176-05E36AF9-525F-4F08-8FEF-881C1218FE3DQ24672467-965787DB-A644-456F-A68C-EE8EC3CEFBF4Q26743557-BBD0411D-71BA-4BA5-BC44-4F57675FBA4FQ27334169-64286EFA-888F-4F60-B280-10354F80C4B6Q28068034-26636F49-0EAD-4D34-9387-29554EC5605DQ31163367-EC758899-028F-4FF2-BAE6-E0AF28D91B77Q33272573-36B6F0CD-EC02-4443-AD7B-C4A73B3A0419Q33602156-E8A5EC4D-4B26-4532-ACF9-E71D3E13CDDCQ33741091-335D2519-DAA2-4282-B1D6-7FB19AB707E2Q33839434-7C2BE62F-F934-4219-BB3A-4AAD1CB940B5Q33978279-C0D0C419-1B56-4E86-9452-3854F3E4C469Q34583647-3AC3D266-8AD4-451D-842C-64FA8D8363C8Q35122201-EA688E88-CBB1-47A8-9F4F-AC6EF813FB77Q35140230-31F8A1C3-7A7A-4F1B-993B-F555C33B38B3Q35808917-07A59C30-FA11-42E9-8482-8E253E478991Q36059834-902A98B6-97BD-452C-BDA7-59B83CB58947Q36756845-F7AEB754-BCFE-4AAF-9B35-85869CE6215BQ36847549-01AC6ACA-1D50-46EB-B034-BA515FD97BF0Q36941459-5CB120CD-28CD-4C9D-8CD6-1DB1F0D81B72Q37423061-6DA3D24B-C85C-48AA-B2A2-CB3051DAE556Q38412911-1EF9E564-9132-41B8-83B8-FD22E1F75A12Q38557891-E3E6EF3A-C875-4B50-804C-362E8D706CCDQ38682214-71F196A3-B23A-4022-A573-308F41C04F40Q39914874-9911C81D-7214-4B43-AA21-033BBC2AC63AQ43078501-DDFE0040-1BBA-4F24-ACB8-439891DB8F9DQ43083058-D5D9E28F-EE9E-463A-B314-1204E40E3381Q44775796-7CC102A3-548C-4398-A8E0-7AF6F23FA4B2Q45206741-2EF49CDE-FB3C-4C03-A720-06637438CA24Q45206745-D0050264-D922-4C06-A666-3501890D5C48Q46987603-CC8EE43A-CB70-4827-AD2E-4D4347D2B087Q46987608-D7781062-7985-406D-A970-B5675930FEB5Q53607695-83E5BE22-518A-48D1-96BE-EC2AF0BA2E6B
P2860
Role of NF-kappaB and cytokine in experimental cancer cachexia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Role of NF-kappaB and cytokine in experimental cancer cachexia.
@en
Role of NF-kappaB and cytokine in experimental cancer cachexia.
@nl
type
label
Role of NF-kappaB and cytokine in experimental cancer cachexia.
@en
Role of NF-kappaB and cytokine in experimental cancer cachexia.
@nl
prefLabel
Role of NF-kappaB and cytokine in experimental cancer cachexia.
@en
Role of NF-kappaB and cytokine in experimental cancer cachexia.
@nl
P2093
P2860
P356
P1476
Role of NF-kappaB and cytokine in experimental cancer cachexia.
@en
P2093
P2860
P304
P356
10.3748/WJG.V9.I7.1567
P407
P50
P577
2003-07-01T00:00:00Z